Friday, August 27, 2021 6:55:06 AM
https://pulse2.com/nrx-pharmaceuticals-nasdaq-nrxp-stock-over-16-increase-explanation/
“As the COVID-19 pandemic continues, so does the need for more innovative, effective and FDA-approved therapies for critically-ill patients with respiratory failure. Cardinal Health is pleased to ensure that COVID-19 patients get access to treatment in a timely and efficient manner.” — Marc DeLorenzo, Senior Vice President of Strategic Sourcing at Cardinal Health ——— Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM